Entry id

1_0fkqnakh

Women at high risk of recurrence with HR positive, HER2 negative breast cancer really do need to avail themselves of all of the proven treatment strategies we have available. And the way I get across is I tell women what their risk of systemic recurrence of disease is, what their risk of loco-regional recurrence is, and I really kind of quantitatively lay out for them what their improvement in outcome will be with each of the proven treatment strategies we have for the patient. So, I write it down and I really make it very clear that every single thing we have that is proven is going to get them the highest possible chance of remaining disease-free